Novel Type V-A CRISPR Effectors Are Active Nucleases with Expanded Targeting Capabilities

por Aliaga Goltsman, Daniela S., Alexander, Lisa M., Devoto, Audra E., Albers, Justine B., Liu, Jason, Butterfield, Cristina N., Brown, Christopher T., Thomas, Brian C.
Publicado 2020

Novel and Engineered Type II CRISPR Systems from Uncultivated Microbes with Broad Genome Editing Capability

por Alexander, Lisa M., Aliaga Goltsman, Daniela S., Liu, Jason, Lin, Jyun-Liang, Temoche-Diaz, Morayma M., Laperriere, Sarah M., Neerincx, Andreas, Bednarski, Christien, Knyphausen, Philipp, Cohnen, Andre, Albers, Justine, Gonzalez-Osorio, Liliana, Fregoso Ocampo, Rodrigo, Oki, Jennifer, Devoto, Audra E., Castelle, Cindy J., Lamothe, Rebecca C., Cost, Gregory J., Butterfield, Cristina N., Thomas, Brian C., Brown, Christopher T.
Publicado 2023